Assessing the link between BACH1/FANCJ and MLH1 in DNA crosslink repair

Environmental and Molecular Mutagenesis

Volumn 51, Issue 6, 2010, Pages 500-507

  Cantor, Sharon B ^a   Xie, Jenny ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

FANCJ; ICL repair; MLH1

Indexed keywords

BRCA1 PROTEIN; FANCONI ANEMIA GROUP J PROTEIN; FANCONI ANEMIA PROTEIN; HELICASE; PROTEIN MLH1; UNCLASSIFIED DRUG; BACH1 PROTEIN, HUMAN; BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; MLH1 PROTEIN, HUMAN; NUCLEAR PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

BREAST CANCER; DNA CROSS LINKING; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; EXCISION REPAIR; GENE MUTATION; GENOMIC INSTABILITY; HOMOLOGOUS RECOMBINATION; HUMAN; NONHUMAN; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; REVIEW; BREAST TUMOR; FEMALE; GENETICS; METABOLISM; MUTATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; BRCA1 PROTEIN; BREAST NEOPLASMS; DNA DAMAGE; DNA REPAIR; FANCONI ANEMIA COMPLEMENTATION GROUP PROTEINS; FEMALE; HUMANS; MUTATION; NUCLEAR PROTEINS;

EID: 77955878471     PISSN: 08936692     EISSN: 10982280     Source Type: Journal    
DOI: 10.1002/em.20568     Document Type: Review

References (58)

1. Barber LJ, Youds JL, Ward JD, McIlwraith MJ, O'Neil NJ, Petalcorin MI, Martin JS, Collis SJ, Cantor SB, Auclair M, Tissenbaum H, West S, Rose A, Boulton S. 2008. RTEL1 maintains genomic stability by suppressing homologous recombination. Cell 135:261-271.
2. Bellacosa A. 2001. Functional interactions and signaling properties of mammalian DNA mismatch repair proteins. Cell Death Differ 8:1076-1092.
3. Bridge WL, Vandenberg CJ, Franklin RJ, Hiom K. 2005. The BRIP1 helicase functions independently of BRCA1 in the Fanconi anemia pathway for DNA crosslink repair. Nat Genet 37:953-957.
4. Brown KD, Rathi A, Kamath R, Beardsley DI, Zhan Q, Mannino JL, Baskaran R. 2003. The mismatch repair system is required for Sphase checkpoint activation. Nat Genet 33:80-84.
5. Cantor S, Drapkin R, Zhang F, Lin Y, Han J, Pamidi S, Livingston DM. 2004. The BRCA1-associated protein BACH1 is a DNA helicase targeted by clinically relevant inactivating mutations. Proc Natl Acad Sci USA 101:2357-2362.
6. Cantor SB, Bell DW, Ganesan S, Kass EM, Drapkin R, Grossman S, Wahrer DC, Sgroi DC, Lane WS, Haber DA, et al. 2001. BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function. Cell 105:149-160.
7. Chandra S, Levran O, Jurickova I, Maas C, Kapur R, Schindler D, Henry R, Milton K, Batish SD, Cancelas JA, et al. 2005. A rapid method for retrovirus-mediated identification of complementation groups in Fanconi anemia patients. Mol Ther 12:976-984.
8. Dao V, Modrich P. 1998. Mismatch-, MutS-, MutL-, and helicase II-dependent unwinding from the single-strand break of an incised heteroduplex. J Biol Chem 273:9202-9207.
9. De Nicolo A, Tancredi M, Lombardi G, Flemma CC, Barbuti S, Di Cristofano C, Sobhian B, Bevilacqua G, Drapkin R, Caligo MA. 2008. A novel breast cancer-associated BRIP1 (FANCJ/BACH1) germ-line mutation impairs protein stability and function. Clin Cancer Res 14:4672-4680.
10. Dronkert ML, Kanaar R. 2001. Repair of DNA interstrand cross-links. Mutat Res 486:217-247.
11. Durant ST, Morris MM, Illand M, McKay HJ, McCormick C, Hirst GL, Borts RH, Brown R. 1999. Dependence on RAD52 and RAD1 for anticancer drug resistance mediated by inactivation of mismatch repair genes. Curr Biol 9:51-54.
12. Greenberg RA, Sobhian B, Pathania S, Cantor SB, Nakatani Y, Livingston DM. 2006. Multifactorial contributions to an acute DNA damage response by BRCA1/BARD1-containing complexes. Genes Dev 20:34-46.
13. Gupta R, Sharma S, Doherty KM, Sommers JA, Cantor SB, Brosh RM Jr. 2006. Inhibition of BACH1 (FANCJ) helicase by backbone discontinuity is overcome by increased motor ATPase or length of loading strand. Nucleic Acids Res 34:6673-6683.
14. Gupta R, Sharma S, Sommers JA, Jin Z, Cantor SB, Brosh RM Jr. 2005. Analysis of the DNA substrate specificity of the human BACH1 helicase associated with breast cancer. J Biol Chem 280:25450-25460.
15. Gupta R, Sharma S, Sommers JA, Kenny MK, Cantor SB, Brosh RM Jr. 2007. FANCJ (BACH1) helicase forms DNA damage inducible foci with replication protein A, interacts physically and functionally with the single-stranded DNA-binding protein. Blood 110:2390-2398.
16. Howlett NG, Taniguchi T, Olson S, Cox B, Waisfisz Q, De Die-Smulders C, Persky N, Grompe M, Joenje H, Pals G, et al. 2002. Biallelic inactivation of BRCA2 in Fanconi anemia. Science 297:606-609.
17. Iyer RR, Pluciennik A, Burdett V, Modrich PL. 2006. DNA mismatch repair: functions and mechanisms. Chem Rev 106:302-323.
18. Jiricny J. 2006. The multifaceted mismatch-repair system. Nat Rev Mol Cell Biol 7:335-346.
19. Kondo E, Horii A, Fukushige S. 2001. The interacting domains of three MutL heterodimers in man: hMLH1 interacts with 36 homologous amino acid residues within hMLH3, hPMS1 and hPMS2. Nucleic Acids Res 29:1695-1702.
20. Kumaraswamy E, Shiekhattar R. 2007. Activation of BRCA1/BRCA2-associated helicase BACH1 is required for timely progression through S phase. Mol Cell Biol 27:6733-6741.
21. Kupfer GM, D'Andrea AD. 1996. The effect of the Fanconi anemia polypeptide FAC, upon p53 induction and G2 checkpoint regulation. Blood 88:1019-1025.
22. Levitus M, Rooimans MA, Steltenpool J, Cool NF, Oostra AB, Mathew CG, Hoatlin ME, Waisfisz Q, Arwert F, de Winter JP, et al. 2004. Heterogeneity in Fanconi anemia: evidence for 2 new genetic subtypes. Blood 103:2498-2503.
23. Levitus M, Waisfisz Q, Godthelp BC, de Vries Y, Hussain S, Wiegant WW, Elghalbzouri-Maghrani E, Steltenpool J, Rooimans MA, Pals G, et al. 2005. The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J. Nat Genet 37:934-935.
24. Levran O, Attwooll C, Henry RT, Milton KL, Neveling K, Rio P, Batish SD, Kalb R, Velleuer E, Barral S, et al. 2005. The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia. Nat Genet 37:931-933.
25. Lin DP, Wang Y, Scherer SJ, Clark AB, Yang K, Avdievich E, Jin B, Werling U, Parris T, Kurihara N, et al. 2004. An Msh2 point mutation uncouples DNA mismatch repair and apoptosis. Cancer Res 64:517-522.
26. Lin X, Trang J, Okuda T, Howell SB. 2006. DNA polymerase zeta accounts for the reduced cytotoxicity and enhanced mutagenicity of cisplatin in human colon carcinoma cells that have lost DNA mismatch repair. Clin Cancer Res 12:563-568.
27. Litman R, Peng M, Jin Z, Zhang F, Zhang J, Powell S, Andreassen PR, Cantor SB. 2005. BACH1 is critical for homologous recombination and appears to be the Fanconi anemia gene product FANCJ. Cancer Cell 8:255-265.
28. McCabe KM, Olson SB, Moses RE. 2009. DNA interstrand crosslink repair in mammalian cells. J Cell Physiol 220:569-573.
29. Mechanic LE, Frankel BA, Matson SW. 2000. Escherichia coli MutL loads DNA helicase II onto DNA. J Biol Chem 275:38337-38346.
30. Mello JA, Acharya S, Fishel R, Essigmann JM. 1996. The mismatch-repair protein hMSH2 binds selectively to DNA adducts of the anticancer drug cisplatin. Chem Biol 3:579-589.
31. Moldovan GL, Pfander B, Jentsch S. 2007. PCNA, the maestro of the replication fork. Cell 129:665-679.
32. Niedernhofer LJ, Lalai AS, Hoeijmakers JH. 2005. Fanconi anemia (cross) linked to DNA repair. Cell 123:1191-1198.
33. O'Brien V, Brown R. 2006. Signalling cell cycle arrest and cell death through the MMR System. Carcinogenesis 27:682-692.
34. Papouli E, Chen S, Davies AA, Huttner D, Krejci L, Sung P, Ulrich HD. 2005. Crosstalk between SUMO and ubiquitin on PCNA is mediated by recruitment of the helicase Srs2p. Mol Cell 19:123-133.
35. Peng M, Litman R, Jin Z, Fong G, Cantor SB. 2006. BACH1 is a DNA repair protein supporting BRCA1 damage response. Oncogene 25:2245-2253.
36. Peng M, Litman R, Xie J, Sharma S, Brosh RM Jr, Cantor SB. 2007. The FANCJ/MutLalpha interaction is required for correction of the cross-link response in FA-J cells. EMBO J 26:3238-3249.
37. Rudolf J, Makrantoni V, Ingledew WJ, Stark MJ, White MF. 2006. The DNA repair helicases XPD, FancJ have essential iron-sulfur domains. Mol Cell 23:801-808.
38. Saydam N, Kanagaraj R, Dietschy T, Garcia PL, Pena-Diaz J, Shevelev I, Stagljar I, Janscak P. 2007. Physical and functional interactions between Werner syndrome helicase and mismatch-repair initiation factors. Nucleic Acids Res 35:5706-5716.
39. Seal S, Thompson D, Renwick A, Elliott A, Kelly P, Barfoot R, Chagtai T, Jayatilake H, Ahmed M, Spanova K, et al. 2006. Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles. Nat Genet 38:1239-1241.
40. Shen X, Do H, Li Y, Chung WH, Tomasz M, de Winter JP, Xia B, Elledge SJ, Wang W, Li L. 2009. Recruitment of fanconi anemia and breast cancer proteins to DNA damage sites is differentially governed by replication. Mol Cell 35:716-723.
41. Siehler SY, Schrauder M, Gerischer U, Cantor S, Marra G, Wiesmuller L. 2009. Human MutL-complexes monitor homologous recombination independently of mismatch repair. DNA Repair (Amst) 8:242-252.
42. Sommers JA, Rawtani N, Gupta R, Bugreev DV, Mazin AV, Cantor SB, Brosh RM Jr. 2009. FANCJ uses its motor ATPase to disrupt protein-DNA complexes, unwind triplexes, and inhibit rad51 strand exchange. J Biol Chem 284:18458-18470.
43. Stojic L, Mojas N, Cejka P, Di Pietro M, Ferrari S, Marra G, Jiricny J. 2004. Mismatch repair-dependent G2 checkpoint induced by low doses of SN1 type methylating agents requires the ATR kinase. Genes Dev 18:1331-1344.
44. Surtees JA, Argueso JL, Alani E. 2004. Mismatch repair proteins: key regulators of genetic recombination. Cytogenet Genome Res 107:146-159.
45. Thompson LH, Hinz JM. 2009. Cellular and molecular consequences of defective Fanconi anemia proteins in replication-coupled DNA repair: mechanistic insights. Mutat Res 668:54-72.
46. Thompson LH, Hinz JM, Yamada NA, Jones NJ. 2005. How Fanconi anemia proteins promote the four Rs: replication, recombination, repair, and recovery. Environ Mol Mutagen 45:128-142.
47. Vaze MB, Pellicioli A, Lee SE, Ira G, Liberi G, Arbel-Eden A, Foiani M, Haber JE. 2002. Recovery from checkpoint-mediated arrest after repair of a double-strand break requires Srs2 helicase. Mol Cell 10:373-385.
48. Walsh T, King MC. 2007. Ten genes for inherited breast cancer. Cancer Cell 11:103-105.
49. Wang W. 2007. Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins. Nat Rev Genet 8:735-748.
50. Wang Y, Cortez D, Yazdi P, Neff N, Elledge SJ, Qin J. 2000. BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev 14:927-939.
51. Wu Q, Christensen LA, Legerski RJ, Vasquez KM. 2005. Mismatch repair participates in error-free processing of DNA interstrand crosslinks in human cells. EMBO Rep 6:551-557.
52. Wu Q, Vasquez KM. 2008. Human MLH1 protein participates in genomic damage checkpoint signaling in response to DNA interstrand crosslinks, while MSH2 functions in DNA repair. PLoS Genet 4:e1000189.
53. Wu Y, Shin-Ya K, Brosh RM Jr. 2008. FANCJ helicase defective in Fanconia anemia and breast cancer unwinds G-quadruplex DNA to defend genomic stability. Mol Cell Biol 28:4116-41128
54. Yamaguchi M, Dao V, Modrich P. 1998. MutS and MutL activate DNA helicase II in a mismatch-dependent manner. J Biol Chem 273:9197-9201.
55. Youds JL, Barber LJ, Ward JD, Collis SJ, O'Neil NJ, Boulton SJ, Rose AM. 2008. DOG-1 is the Caenorhabditis elegans BRIP1/FANCJ homologue and functions in interstrand cross-link repair. Mol Cell Biol 28:1470-1479.
56. Yu X, Chini CC, He M, Mer G, Chen J. 2003. The BRCT domain is a phospho-protein binding domain. Science 302:639-642.
57. Zhang N, Liu X, Li L, Legerski R. 2007. Double-strand breaks induce homologous recombinational repair of interstrand cross-links via cooperation of MSH2, ERCC1-XPF, REV3, and the Fanconi anemia pathway. DNA Repair (Amst) 6:1670-1678.
58. Zhang N, Lu X, Zhang X, Peterson CA, Legerski RJ. 2002. hMutS-beta is required for the recognition and uncoupling of psoralen interstrand cross-links in vitro. Mol Cell Biol 22:2388-2397.